Genomtec (GMT) Q4 2024 earnings summary

Executive summary

• Audit opinion issued with a qualification regarding the impairment test of completed development work assets, due to lack of revenue and contracts, making assumptions unverifiable.

• Financial statements present a true and fair view except for the matter described in the qualified opinion.

• Key audit matters include going concern and recognition of grant income.

Financial highlights

• Total assets and liabilities as of December 31, 2024, amount to PLN 17,041 thousand.

• Net loss and total comprehensive loss for the year: PLN 11,208 thousand.

• Equity decreased by PLN 702 thousand during the year.

• Cash and cash equivalents increased by PLN 2,528 thousand over the year.

Key financial ratios and metrics

• Completed development work assets represent 34.7% of the balance sheet total as of December 31, 2024.